Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ascorbic acid + carbonyl iron + folic acid + nicotinamide + pyridoxine + riboflavin + thiamine + zinc sulfate
- Development stage
- Unknown
- Lead developer
- Al-Madina Pharmaceuticals
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Carbium is an oral multi-nutrient (hematinic) combination supplement manufactured by Al-Madina Pharmaceuticals. It is formulated as a capsule containing carbonyl iron, folic acid, zinc sulfate monohydrate, thiamine mononitrate (vitamin B1), riboflavin (vitamin B2), pyridoxine hydrochloride (vitamin B6), nicotinamide (vitamin B3), and ascorbic acid (vitamin C). Carbium is indicated for the treatment and prophylaxis of iron, folic acid, zinc, vitamin B-complex, and vitamin C deficiencies, particularly during pregnancy, lactation, and in geriatric patients experiencing generalized weakness. The carbonyl iron component provides a highly bioavailable and low-toxicity source of elemental iron to support hemoglobin synthesis, while the accompanying vitamins and zinc act as essential cofactors for erythropoiesis, DNA synthesis, and cellular metabolism.
- Brand names
- Carbium
- Other names
- carbonyl iron + folic acid + vitamin b complex + vitamin c + zinc sulfatecarbonyl iron + folic acid + zinc + vitamin b complex + vitamin ccarbonyl iron + folic acid + zinc sulfate + thiamine + riboflavin + pyridoxine + nicotinamide + ascorbic acidcarbonyl iron + folic acid + zinc sulfate + vitamin b complex + ascorbic acid
Beyond the preview
Go deeper on ascorbic acid + carbonyl iron + folic acid + nicotinamide + pyridoxine + riboflavin + thiamine + zinc sulfate.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ascorbic acid + carbonyl iron + folic acid + nicotinamide + pyridoxine + riboflavin + thiamine + zinc sulfate.